Hologic, Inc.
Hologic, Inc.
HOLX
Valuace
18
Růst
0
Zdraví
69
Cena
$ 74.19
Dnes
--0.04 (-0.05%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
16.5B
Obrat
4B
Zisk
1B
Aktiva
9B
Dluh
3B
ROE
0%
ROA
0%
PE
31
PS
4
Cena 1R
52-75
⌀ Cena
67.02
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
04-02-2026
Poslední dividenda

Profil

Společnost Hologic, Inc. vyvíjí, vyrábí a dodává diagnostické produkty, lékařské zobrazovací systémy a chirurgické přípravky pro zdraví žen prostřednictvím včasné detekce a léčby ve Spojených státech, Evropě, Asii a Tichomoří a v mezinárodním měřítku. Působí ve čtyřech segmentech: diagnostika, zdraví prsů, gyn chirurgie a skeletální zdraví. Společnost poskytuje molekulární diagnostické testy Aptima pro detekci infekčních mikroorganismů; testy virové zátěže Aptima na HIV, hepatitidu C a hepatitidu B; testy Aptima SARS-CoV-2 a Panther Fusion SARS-CoV-2 pro detekci SARS-CoV-2; ThinPrep systém pro použití v cytologických aplikacích; Rapid Fetal Fibronectin Test, který pomáhá lékařům posoudit riziko předčasného porodu; a různé diagnostické testy pro detekci Streptokoku skupiny B. Nabízí také snímkování a analýzu prsou, jako jsou 2D a 3D digitální mamografické systémy a čtecí pracovní stanice, minimálně invazivní naváděcí systémy a zařízení pro biopsii prsu, markery a lokalizace místa biopsie prsu, radiologie vzorku a řešení ultrazvuku a konektivity; a přípravky pro chirurgii, která šetří prsa. Společnost dále poskytuje systém endometriální ablace NovaSure pro léčbu abnormálního děložního krvácení; MyoSure Hysteroscopic Tissue Removal System pro odstraňování fibroidů, polypů a dalších patologických procesů v děloze; a Fluent Fluid Management System, který zajišťuje tekutou destilaci během diagnostických a operačních hysteroskopických procedur. Dále nabízí Rentgenový systém s duální energií Horizon DXA a mini C-arm Fluoroscan Insight FD k provádění minimálně invazivních ortopedických chirurgických zákroků. Společnost prodává své výrobky prostřednictvím přímých prodejních a servisních sil a nezávislých distributorů a obchodních zástupců. Hologic, Inc. byla založena v roce 1985 a sídlí v Marlborough ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
7063
Založení
1990-03-01
Adresa
250 Campus Drive
CEO
Stephen P. MacMillan

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues4,126.44,100.54,030.34,030.44,862.85,632.33,776.43,367.33,217.93,058.82,832.72,705.02,530.72,492.32,002.71,789.31,679.6
Cost of Revenues1,947.01,599.41,802.51,958.91,865.41,836.51,548.92,059.21,521.21,437.81,269.41,272.31,285.21,330.91,008.2866.2942.9
Gross Profit2,179.42,501.12,227.82,071.52,997.43,795.82,227.51,308.11,696.71,621.01,563.31,432.71,245.51,161.4994.4923.2736.6
Revenue 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Total Revenues1,047.81,049.51,023.81,005.31,021.8988.01,011.41,017.81,013.1945.3
Cost of Revenues461.4410.4447.2628.0441.3430.3451.1455.3445.6445.0
Gross Profit586.4639.1576.6377.3580.5557.7560.3562.5567.5500.3
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0294.3283.4276.3222.5232.2218.7232.8232.1214.9203.2197.6131.0116.7104.3
Selling General & Admin Expenses0.00.00.0987.61,038.0994.4840.6897.2910.7841.9682.4624.0591.5569.8542.4445.5407.1
Depreciation & Amortization252.1299.8309.0323.4464.5405.5409.1463.1480.3449.2465.4491.4113.8112.672.058.354.9
Total Operating Expenses1,457.81,786.81,345.21,310.01,366.61,312.91,102.81,181.41,188.71,137.21,004.2949.1908.5880.1745.8536.1566.3
Operating Income721.6714.3882.6668.41,640.22,480.31,105.0134.4-237.91,370.2548.6455.1279.7-906.3113.7374.469.9
Operating Income TTM 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
R&D Expenses0.00.00.00.00.00.00.00.00.072.9
Selling General & Admin Expenses0.00.00.00.00.00.00.00.00.0232.4
Depreciation & Amortization26.379.570.176.274.074.672.373.788.475.5
Total Operating Expenses349.4402.1322.0384.3350.7327.7316.3319.2369.3311.5
Operating Income237.0237.0254.6-7.0229.8230.0244.0243.3198.2132.5
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income69.974.4108.7120.512.91.44.34.66.33.80.71.31.31.32.31.91.3
Interest Expense95.242.7122.1111.195.193.6116.5140.8148.7153.2155.3205.5220.6281.1140.3114.8126.2
Other Expense-58.0-33.1-17.57.7-52.0-119.2-103.1-229.7-784.2896.110.8-102.2-68.3-1,193.2-170.0-44.9-100.4
IBT663.6681.2865.1676.11,588.22,361.11,001.9-95.3-418.61,230.5415.3177.248.1-1,193.0-61.7227.4-55.0
Income Tax Expense119.7115.575.6220.1286.2491.4-108.6-55.1-307.3475.084.545.630.8-20.112.070.27.8
Net Income543.9565.7789.5456.01,302.01,871.51,115.2-40.2-111.3755.5330.8131.617.3-1,172.8-73.6157.2-62.8
Net Income TTM 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Interest Income19.718.916.414.924.228.428.424.027.935.9
Interest Expense27.69.628.929.130.531.931.932.326.028.1
Other Expense-7.3-9.6-19.6-21.517.7-8.4-3.3-31.8-6.913.1
IBT229.7227.4235.0-28.5247.5221.6240.7211.5191.3145.6
Income Tax Expense50.640.140.1-11.146.543.046.241.6-55.255.0
Net Income179.1187.3194.9-17.4201.0178.6194.5169.9246.590.6
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$1.85$5.18$7.28$4.24$-0.15$-0.40$2.70$1.18$0.47$0.06$-4.36$-0.28$0.60$-0.24
EPS Diluted$0.00$0.00$0.00$1.83$5.13$7.21$4.21$-0.15$-0.40$2.64$1.16$0.45$0.06$-4.36$-0.28$0.59$-0.24
Shares Outstanding224.4227.2235.7246.8251.5257.0262.7269.4275.1279.8280.2280.6275.5268.7264.0261.1258.7
Diluted Shares Outstanding225.9227.6237.6248.8253.8259.7264.6269.4275.1285.7286.2289.5278.4268.7264.0264.3258.7
Per Share Data TTM 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.37
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.37
Shares Outstanding224.4225.7224.3225.8230.3233.8234.6235.9238.6245.1
Diluted Shares Outstanding225.9225.7225.5225.8232.1236.0236.5237.6240.2247.1
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents2,439.12,160.22,722.52,339.51,170.3701.0601.8666.7540.6548.4492.7741.6829.4566.1712.3515.6
Short Term Investments8.5173.416.20.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments2,439.12,333.62,722.52,339.51,170.3701.0601.8666.7540.6548.4492.7741.6829.4566.1712.3515.6
Accounts Receivable628.5600.4625.6617.6942.71,028.9648.7579.2533.5447.0416.1396.0409.3409.3318.7283.1
Inventory665.5679.8617.6623.7501.2395.1444.9384.1331.6274.7283.1330.6289.4367.2230.5192.5
Other Current Assets263.9209.5218.8281.2554.597.397.293.272.956.555.558.296.1208.681.3107.7
Total Current Assets3,997.03,823.34,184.53,862.03,168.72,222.31,792.61,723.21,478.61,326.61,266.41,565.81,624.11,563.01,342.91,098.9
Current Assets 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Cash And Equivalents1,735.21,735.21,429.51,782.12,160.22,439.12,180.01,932.12,722.52,765.0
Short Term Investments143.9143.9191.5190.6173.40.00.00.016.224.0
Total Cash & ST Investments1,879.11,879.11,621.01,972.72,333.62,439.12,180.01,932.12,722.52,765.0
Accounts Receivable609.3609.3644.4631.4600.4628.5647.1670.9625.6686.8
Inventory713.7713.7716.7707.1679.8665.5649.2633.6617.6680.1
Other Current Assets219.3219.3226.6182.4209.5263.9312.4257.6218.8241.1
Total Current Assets3,421.43,421.43,208.73,493.63,823.33,997.03,788.73,494.24,184.54,339.3
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment528.8630.0517.0481.6564.7491.5473.0478.2491.2460.2457.1461.9491.5508.0238.7251.7
Goodwill3,291.13,443.13,281.33,236.53,281.62,657.92,563.72,533.23,171.22,803.12,808.22,810.82,814.53,942.82,290.32,108.8
Intangible Assets687.6844.6888.61,280.61,659.21,307.51,459.82,398.62,753.92,643.43,023.23,433.63,906.74,301.32,090.82,118.9
Long-Term Investments6.2150.7-20.25.59.511.454.18.83.04.525.045.037.529.00.00.0
Other Long-Term Assets361.6135.5267.9188.8214.3489.790.376.084.969.9115.258.2163.9121.446.147.5
Total Long-Term Assets4,893.15,332.74,954.85,209.25,751.24,973.54,818.55,507.76,501.05,990.46,403.76,848.97,376.78,914.14,665.94,527.0
Total Assets8,890.19,156.09,139.39,071.28,919.97,195.86,611.17,230.97,979.67,317.07,670.18,414.79,000.810,477.16,008.85,625.8
Long-Term Assets 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Property, Plant & Equipment570.5570.5555.8537.2630.0528.8524.8527.0517.0493.3
Goodwill3,643.93,643.93,624.03,422.93,443.13,291.13,292.43,305.93,281.33,298.2
Intangible Assets642.2642.2673.8793.3844.6687.6751.9832.7888.6940.1
Long-Term Investments0.00.00.047.9150.70.00.00.0-20.2-19.4
Other Long-Term Assets528.1528.1482.8433.8135.5385.6356.6309.7267.9267.0
Total Long-Term Assets5,384.75,384.75,336.45,235.15,332.74,893.14,925.74,975.34,954.84,998.6
Total Assets8,806.18,806.18,545.18,728.79,156.08,890.18,714.48,469.59,139.39,337.9
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable202.0203.8175.2197.7215.9178.8186.5192.2166.6156.9117.092.180.587.263.557.5
Short-Term Debt40.764.8310.515.0313.0324.9271.4599.71,150.8296.0391.8114.5563.864.4140.61.4
Other Current Liabilities540.7486.3490.8538.5599.9549.5432.7437.8376.9287.6272.1262.1311.7380.0184.7183.1
Current Liabilities1,002.41,037.21,207.3937.71,326.81,239.31,070.11,402.61,865.5901.9944.0619.61,088.4661.3509.5441.9
Current Liabilities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Accounts Payable192.7192.7208.6236.7203.8202.0202.5183.8175.2180.6
Short-Term Debt3.46.859.550.164.840.740.640.6310.534.7
Other Current Liabilities553.7550.3508.3528.1486.3540.7503.5484.0460.1499.4
Current Liabilities962.5962.5989.71,002.41,037.21,002.4954.6899.01,207.3981.3
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt2,505.62,593.22,593.62,808.42,712.22,713.92,783.62,704.62,172.13,049.43,248.04,153.24,242.14,971.21,488.61,447.1
Capital Leases12.9123.418.498.2119.4108.454.758.158.434.834.034.133.533.30.00.0
Def. Tax Liability17.8371.220.290.8250.5201.8286.2498.2973.6982.61,178.41,375.41,535.31,771.6957.4955.6
Total Liabilities3,939.24,026.04,122.44,195.04,701.34,488.54,332.04,802.15,194.95,174.35,590.96,351.77,059.37,516.13,071.92,927.3
Long-Term Liabilities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Long-Term Debt2,519.12,519.12,471.52,490.32,593.22,518.52,527.92,537.42,593.62,805.5
Capital Leases13.513.513.514.4123.412.913.817.985.919.1
Def. Tax Liability46.646.646.653.7371.217.818.419.820.219.4
Total Liabilities3,963.63,963.63,926.43,955.44,026.03,939.23,870.03,815.74,122.44,155.9
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock3.03.03.03.03.02.92.92.92.92.92.82.82.72.72.62.6
Retained Earnings2,667.22,845.82,056.31,600.3298.3-1,573.2-2,688.7-2,494.0-2,382.7-3,138.2-3,469.0-3,600.6-3,616.4-2,443.6-2,369.9-2,527.1
Comprehensive Income-139.5-111.5-147.6-238.2-59.1-49.7-42.3-25.5-16.2-32.3-14.52.620.46.82.00.1
Total Common Equity4,950.95,130.05,016.94,876.24,218.62,705.22,279.12,428.82,784.72,142.72,079.22,063.01,941.52,961.02,936.92,698.5
Total Common Equity 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Common Stock3.03.03.03.03.03.03.03.03.03.0
Retained Earnings3,224.33,224.33,029.43,046.82,845.82,667.22,472.72,302.82,056.31,965.7
Comprehensive Income-90.1-90.1-140.1-162.7-111.5-139.5-137.0-118.8-147.6-113.6
Total Common Equity4,842.54,842.54,618.74,773.35,130.04,950.94,844.44,653.85,016.95,182.0
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt2,559.22,658.02,818.22,823.43,025.23,038.83,055.03,304.33,322.93,345.43,639.84,267.74,805.95,035.61,488.61,448.4
Book Value4,950.95,130.05,016.94,876.24,218.62,707.32,279.12,428.82,784.72,142.72,079.22,063.01,941.52,961.02,936.92,698.5
Other 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value4,842.54,842.54,618.74,773.35,130.04,950.94,844.44,653.85,016.95,182.0
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income701.5565.7789.5456.01,302.01,869.71,110.5-40.2-111.3755.5330.8131.617.3-1,172.8-73.6157.2-62.8
Depreciation & Amortization309.9299.8309.0323.4430.1406.9376.0463.1480.3449.2465.4491.4523.2516.0345.8304.7294.8
Stock-Based Compensation88.184.382.379.666.765.083.362.065.068.265.459.350.052.340.635.534.2
Change Working Capital12.2-20.484.111.8454.213.0-636.3-161.3-26.2-103.256.498.544.564.528.2-13.2-1.4
Change In Accounts Receivable47.07.841.0-1.5272.3110.9-427.1-76.5-38.2-41.5-31.8-30.37.94.1-11.0-17.1-20.2
Change In Accounts Payable23.8-11.322.2-23.0-14.420.4-4.9-5.523.9-10.640.125.511.8-6.43.82.67.2
Change In Inventories-3.5-1.3-47.4-4.9-136.6-84.1-25.3-63.0-50.6-11.67.643.9-44.725.2-12.2-32.2-5.2
Other Non-cash Items437.9269.392.4289.538.945.957.5557.6802.4-804.225.0154.1116.51,231.8184.520.0313.7
Cash from Operations1,176.90.00.01,051.22,125.72,330.4896.6649.5732.98.3787.2786.1508.4493.8370.2456.0456.7
Cash Flow From Operating Activities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Net Income179.1187.2194.9-17.4201.0178.6194.5169.9246.590.6
Depreciation & Amortization69.679.570.176.274.074.565.081.073.975.5
Stock-Based Compensation26.912.313.528.430.10.014.625.828.719.0
Change Working Capital-51.273.080.2-96.4-77.2106.954.434.6-84.335.0
Change In Accounts Receivable18.04.648.6-3.7-41.743.517.618.1-38.249.5
Change In Accounts Payable7.81.1-17.6-31.036.2-4.30.00.00.0-2.7
Change In Inventories-8.633.47.1-5.7-36.1-0.3-16.7-17.4-13.043.6
Other Non-cash Items6.633.413.7241.3-19.126.877.3-18.9-44.847.5
Cash from Operations0.00.00.00.00.00.00.00.00.0258.7
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-162.4-78.2-72.4-150.2-127.2-162.7-156.4-113.6-105.6-107.6-98.5-89.4-80.2-90.1-83.3-64.0-52.5
Acquisitions-67.0-321.5-297.3-5.0-158.6-1,164.719.9-128.8-76.5306.9-4.00.010.162.1-3,772.2-218.4-87.4
Investments-42.5-181.9-267.7-10.00.00.0-2.4-3.0-6.00.0-5.2-6.4-29.7-7.7-0.3-0.1-0.8
Sales of Investment-22.7176.00.00.00.00.00.0-4.50.187.136.310.036.22.18.04.90.7
Other Investing Activities10.80.00.013.179.5-2.2-2.7-30.8-7.2-0.63.0-0.3-3.452.5-3.111.073.0
Cash from Investing-241.30.00.0-152.1-206.3-1,329.6-141.6-280.7-195.2285.8-68.4-86.1-67.018.8-3,850.8-266.6-67.0
Cash Flow From Investing Activities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Capital Expenditure-20.4-16.7-12.8-40.2-14.8-30.3-33.9-28.0-38.0-52.5
Acquisitions0.00.01.3-322.5-0.3-297.30.00.00.06.8
Investments-24.0-148.90.00.00.0-267.70.00.00.00.0
Sales of Investment48.048.048.00.032.00.00.00.00.00.0
Other Investing Activities0.00.00.00.00.00.00.00.00.0-10.3
Cash from Investing0.00.00.00.00.00.00.00.00.0-56.0
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-285.40.00.0-19.0-1,703.5-1,369.7-797.5-2,280.7-4,152.3-529.5-692.8-3,821.7-595.0-265.00.0-1.4-2.8
Debt Issued23.52,658.0-160.213.81,501.71,356.1781.32,031.44,133.7507.0398.43,193.856.835.33,547.041.51,451.3
Issuance of Common Stock53.10.00.043.051.351.30.049.833.249.038.50.081.40.00.025.412.6
Repurchase of Common Stock-988.1-752.9-835.1-474.8-542.1-409.7-653.6-200.1-275.8-200.1-250.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.0-51.30.0-49.8-33.2-393.0-250.00.00.00.00.00.00.0
Other Financing Activities-14.20.00.0-32.41,438.31,249.6791.22,049.34,023.3764.4494.62,885.0-11.516.23,328.1-16.4-177.3
Cash from Financing-1,262.40.00.0-483.2-756.0-529.8-659.9-431.5-404.8-309.2-659.7-936.7-525.1-248.83,328.17.7-167.6
Cash Flow From Financing Activities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Debt Repaid0.00.00.00.00.00.00.00.00.0-4.4
Debt Issued2,522.52,522.5-8.5-9.4-117.698.8-9.3-9.5-240.21.5
Issuance of Common Stock0.00.00.00.00.00.00.00.00.00.0
Repurchase of Common Stock0.00.0-35.6-200.2-517.3-58.3-100.3-0.1-693.0-211.2
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.05.0
Cash from Financing0.00.00.00.00.00.00.00.00.0-210.6
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-325.9-200.7-595.5416.21,169.2469.399.2-64.9126.1-7.857.1-244.8-86.4262.1-151.9196.7222.4
Closing Cash Balance2,439.11,959.52,160.22,755.72,339.51,170.3701.0601.8666.7540.6548.4491.3736.1822.5560.4712.3515.6
Cash position 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Net Change in Cash208.5224.3305.7-352.6-378.1-278.9259.1247.9-823.6-9.3
Closing Cash Balance2,168.01,959.51,735.21,429.51,782.12,160.22,439.12,180.01,932.12,755.7
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow1,014.5920.11,145.0901.01,998.52,167.7740.2535.9627.3-99.3688.7696.7428.2403.7286.9392.0404.2
Real Free Cash Flow926.4835.81,062.7821.41,931.82,102.7656.9473.9562.3-167.5623.3637.4378.2351.4246.4356.5370.1
Free Cash Flow 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Free Cash Flow215.2324.7330.5129.2142.3336.7371.9264.4182.0206.2
Real Free Cash Flow188.3312.4317.0100.8112.2336.7357.3238.6153.3187.2
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E31.3-21.91703.4
P/S4.13.767.9
P/B3.53.825.8
P/FCF18.513396.3
Market cap$16.5$55.6
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %37.8 %0 %
Debt to Income463.8 %-512.9 %0 %
Debt to Free cash flow274.6 %23.4 %0 %
Interest expense percentage13.2 %54 %38.7 %
Current ratio3.6 2.3 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE11.2 %7.9 %0 %
ROA6.2 %4.3 %0 %
CapEx to Revenue2.2 %3.3 %10.6 %
RaD to Revenue0 %6.6 %0 %
ROEM583,649.2 450410.9

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin52.8 %52.5 %79.8 %
Operating margin17.5 %15.3 %29.6 %
Net margin13.2 %7.7 %27.3 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %2 %0 %
Dividend payout percentage0 %-386 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding225.9 mil 264.3 mil
Employee count7.1 tis 3.7 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader